Trojer Patrick
Chief Scientific Officer at CONSTELLATION PHARMACEUTICALS INC
- Sold, on record
- $1.8M
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 6, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CONSTELLATION PHARMACEUTICALS INCChief Scientific Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CONSTELLATION PHARMACEUTICALS INCUnusualOct 23 2019
Sold 10,285 shares at $15.01 ($154k)
Trojer Patrick, Chief Scientific Officer
Sold 55.6% of holdings ($278k position)8,222 shares leftFirst sale on recordFiling
- 2 Form 4 sale CONSTELLATION PHARMACEUTICALS INCPlan not statedNov 5 +13 days
Sold 1,250 shares at $15.01 ($19k)
Trojer Patrick, Chief Scientific Officer
Sold 13.2% of holdings ($142k position)8,222 shares leftFiling
- 3 Form 4 sale CONSTELLATION PHARMACEUTICALS INCUnusualNov 6 +1 day
Sold 46,142 shares at $25.07 ($1.2M)
Trojer Patrick, Chief Scientific Officer
Sold 100% of holdings ($1.2M position)0 shares leftFiling
- 4 Form 4 sale CONSTELLATION PHARMACEUTICALS INCUnusualMay 6 +182 days
Sold 10,000 shares at $45.16 ($452k)
Trojer Patrick, Chief Scientific Officer
Sold 100% of holdings ($452k position)0 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 6, 2020 | CONSTELLATION PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,000 | $452k | 100.0% | Unusual | SEC |
| Nov 6, 2019 | CONSTELLATION PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 46,142 | $1.2M | 100.0% | Unusual | SEC |
| Nov 5, 2019 | CONSTELLATION PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 1,250 | $19k | 13.2% | Plan not stated | SEC |
| Oct 23, 2019 | CONSTELLATION PHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 10,285 | $154k | 55.6% | Unusual | SEC |